Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas T Schulz

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Infection Control and Hospital Epidemiology|November 19, 2020
Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitoninMichael S Pulia, Ian Wolf, Rebecca J Schwei, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activityWarren E Rose, Lucas T Schulz, David Andes, et al.
Hospital Pharmacy|June 1, 2011
Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous AdmixtureLucas T Schulz, Edmund J Elder, Karen J Jones, et al.
JAMA Network Open|March 27, 2023
Neutropenic Fever-Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 PandemicCourtney J Baus, Broc Kelley, Elizabeth Dow-Hillgartner, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Impact of Triazole Therapeutic Drug Monitoring Availability and TimingErin K McCreary, Meg Bayless, Ahn P Van, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomesJennifer K Ng, Lucas T Schulz, Warren E Rose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 24, 2021
Association of Penicillin or Cephalosporin Allergy Documentation and Antibiotic Use in Hospitalized Patients with PneumoniaChristian M Mancini, Megan Wimmer, Lucas T Schulz, et al.
Drugs - Real World Outcomes|June 28, 2020
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System ExperienceLauren E Brownell, Meagan L Adamsick, Erin K McCreary, et al.
JAMA Internal Medicine|June 21, 2021
Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 PandemicAlexander J Lepak, Lindsay N Taylor, Carolyn A Stone, et al.
Diagnostic Microbiology and Infectious Disease|October 23, 2018
In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistancePatrick M Kinn, Derrick J Chen, Thomas M Gihring, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Infection Control and Hospital Epidemiology|November 19, 2020
Antibiotic prescribing patterns for coronavirus disease 2019 (COVID-19) in two emergency departments with rapid procalcitoninMichael S Pulia, Ian Wolf, Rebecca J Schwei, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activityWarren E Rose, Lucas T Schulz, David Andes, et al.
Hospital Pharmacy|June 1, 2011
Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous AdmixtureLucas T Schulz, Edmund J Elder, Karen J Jones, et al.
JAMA Network Open|March 27, 2023
Neutropenic Fever-Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 PandemicCourtney J Baus, Broc Kelley, Elizabeth Dow-Hillgartner, et al.
Antimicrobial Agents and Chemotherapy|July 24, 2019
Impact of Triazole Therapeutic Drug Monitoring Availability and TimingErin K McCreary, Meg Bayless, Ahn P Van, et al.
Antimicrobial Agents and Chemotherapy|October 23, 2013
Daptomycin dosing based on ideal body weight versus actual body weight: comparison of clinical outcomesJennifer K Ng, Lucas T Schulz, Warren E Rose, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 24, 2021
Association of Penicillin or Cephalosporin Allergy Documentation and Antibiotic Use in Hospitalized Patients with PneumoniaChristian M Mancini, Megan Wimmer, Lucas T Schulz, et al.
Drugs - Real World Outcomes|June 28, 2020
Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System ExperienceLauren E Brownell, Meagan L Adamsick, Erin K McCreary, et al.
JAMA Internal Medicine|June 21, 2021
Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescriptions With the COVID-19 PandemicAlexander J Lepak, Lindsay N Taylor, Carolyn A Stone, et al.
Diagnostic Microbiology and Infectious Disease|October 23, 2018
In vitro evaluation of meropenem-vaborbactam against clinical CRE isolates at a tertiary care center with low KPC-mediated carbapenem resistancePatrick M Kinn, Derrick J Chen, Thomas M Gihring, et al.
Pageof 6